Using the differentially expressed gene list, we identified the pathways that were significantly affected (p < 0.0001) in STAP-1 KO CML LSCs using Ingenuity Pathway Analysis. This evidence concerns the gene STAP1 and chronic myelogenous leukemia, BCR-ABL1 positive.